In this proposal, we outline an Ontario population-wide longitudinal cohort study that will examine the relationship between serum lithium levels and renal outcomes in older lithium users.… Read more “Lithium levels and poor renal, neurological, and cancer outcomes in older lithium users: A series of population-based pharmacoepidemiology”
Published or In-Press Refereed Papers: Full-Length Manuscripts: Marshe, V., Macieukiewicz, M., Rej, S., Tiwari, AK, Kennedy, JL, Lenze, E., Blumberger, D., Karp, J., Reynolds, CF., Mulsant, BH,… Read more “Publications”
Project Summary: Objectives: Physicians rarely engage severe and persistent mental illness (SPMI) patients in end-of-life care discussion despite an increased risk of debilitating medical illnesses and mortality.… Read more ““End-of-life Care Preferences in Patients with Severe and Persistent Mental Illness and Chronic Medical Conditions: A Comparative Cross-sectional Study””
Background: According to the World Health Organization, one million people die by suicide each year worldwide and the rate of attempted suicide is ten times greater. A… Read more ““Meditation Intervention for the Treatment of Depression Symptoms and Cognitive Inhibition in Depressed Patients at Risk for Suicide: A Randomized Controlled Trial””
Background: Lithium remains the gold-standard treatment for bipolar disorder, with 30-40% of patients with responding preferentially to this medication 1-3. Additionally, lithium is commonly used in treatment-resistant… Read more ““Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial””
Background: Up to 50% of hemodialysis patients suffer from symptoms of depression and/or anxiety. Access to traditional pharmacotherapies and psychotherapies for depression or anxiety in this patient… Read more ““Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Dialysis: A Randomized Control Trial””
This is the excerpt for your very first post.